HealthQuill - HealthQuill

The WHO’s scientific advisors have called on China to release all data relating to the COVID-19 origins after a new report hinted at the possibility of raccoon dogs as the first source of the virus.

WHO advisors urge China to release all data on COVID-19 origins

The WHO’s scientific advisors have called on China to release all data relating to the COVID-19 origins after a new report hinted at

by HealthQuill
March 20, 2023
0 Comments

India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of GlaxoSmithKline.

Drugs Medical Pharma

Glenmark’s drug to treat nausea, psychosis gets FDA nod

India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of

by HealthQuill
March 20, 2023
0 Comments

Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.

Drugs Health Medical Pharma

FDA panel votes for full approval of Pfizer’s covid pill Paxlovid

The FDA’s advisory panel recommended full approval of Pfizer’s Covid antiviral treatment Paxlovid for high-risk adults.

by HealthQuill
March 18, 2023
0 Comments

The WHO slammed the Chinese authorities for not being transparent in sharing data related to COVID-19 origins and urged Beijing to conduct "investigations and share the results" with the global health agency.

Drugs Health Medical Pharma

New report opens a can of worms on COVID-19 origins, WHO steps in

The WHO slammed the Chinese authorities for not being transparent in sharing data related to COVID-19 origins and urged Beijing to conduct "investigations

by HealthQuill
March 18, 2023
0 Comments

Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs in a programme aimed at valuing the efficacy of its Lyfe digital therapeutical platform.

Drugs Health Pharma

83.3% ACS patients achieve normality: Lupin Digital Health study

Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs

by HealthQuill
March 17, 2023
0 Comments

Jubilant HollisterStier, a subsidiary of India's Jubilant Pharmova, has got Canada's nod for a partially repayable loan of CAD 23.8 million ($17.7 million) for expansion in Montreal.

Drugs Medical Pharma

Jubilant HollisterStier gets $17.7 million Canadian funding

Jubilant HollisterStier, a subsidiary of India's Jubilant Pharmova, has got Canada's nod for a partially repayable loan of CAD 23.8 million ($17.7 million)

by HealthQuill
March 17, 2023
0 Comments

Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.

Drugs Medical Pharma

Sanofi lowers Lantus insulin costs by 78% in U.S. market

Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.

by HealthQuill
March 17, 2023
0 Comments

Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in the US sites for its drug to treat advanced solid tumours and lymphomas.

Drugs Medical Pharma

Glenmark gets FDA nod for trials in US on tumour, cancer patients

Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in

by HealthQuill
March 16, 2023
0 Comments

Medical Pharma

Mediar bags $105 mn from big pharmas to pursue fibrosis treatments

Mediar Therapeutics gets $105 million financing from Novartis, Pfizer, Eli Lilly and Bristol Myers to advance portfolio of first-in-class fibrosis therapies.